Tumor heterogeneity has led to breast cancer classification into four intrinsic subtypes, luminal A, luminal B, HER2-enriched, and basal-like breast cancer, and these are closely related to the development and prognosis of breast cancer [45–48]. Here, ERBB2 is linked to breast cancer.